Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Locations section now lists Beijing Municipality as a separate location, replacing the previous combined Beijing Municipality Locations. Page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 in the header/footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved a general government funding status notice about potential updates and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedFormatting and layout updates were applied without changing core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check89 days agoChange DetectedCore content updated with a government-operational notice and a version bump from v3.1.0 to v3.2.0; no other significant content changes detected.SummaryDifference6%

- Check96 days agoChange DetectedPage updated to version v3.1.0 and added contact details (email and phone); previous version v3.0.2 removed.SummaryDifference0.1%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.